BOTHELL, Wash., March 2 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will release its fourth quarter 2008 financial results on Thursday, March 12, 2009 after the market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time. During the call, Cardiac Science management will discuss the financial results for the fourth quarter as well as the current business outlook.
To access the conference call, please dial 800-257-3401. International participants can dial 303-262-2125. The call will also be webcast live at www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11125955#. An archived webcast will also be available at www.cardiacscience.com for 90 days.
For more information, Company Contact: Investor Contact: Media Contact: Mike Matysik Doug Sherk Christopher Gale Cardiac Science Corporation Jenifer Kirtland EVC Group, Inc. Sr. Vice President and CFO EVC Group, Inc. (646) 201-5431 (425) 402-2009 (415) 896-6820 (203) 570-4681 firstname.lastname@example.org
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit www.cardiacscience.com.
|SOURCE Cardiac Science Corporation|
Copyright©2009 PR Newswire.
All rights reserved